{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-076526","form_type":"8-K","ticker":"NDRA","cik":"0001681682","company_name":"ENDRA Life Sciences Inc.","filed_at":"2026-07-09T10:08:49+00:00","discovered_at":"2026-07-09T10:10:00.254963+00:00","generated_at":"2026-07-09T10:10:04.534048+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"ENDRA Life Sciences regains Nasdaq compliance; subject to one-year monitor","bullets":["Nasdaq notified ENDRA on July 8, 2026 that it regained compliance with the $2.5M Minimum Stockholders' Equity Requirement.","Company had been below requirement; requested hearing on April 27, 2026, hearing held May 28, 2026.","Subject to Discretionary Panel Monitor for one year from July 1, 2026.","If non-compliant again during monitor period, no cure period; immediate delisting process begins.","Company can request a new hearing if a delisting determination is issued."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-076526","json":"https://secwatch.observer/filing/0001213900-26-076526.json","markdown":"https://secwatch.observer/filing/0001213900-26-076526.md","text":"https://secwatch.observer/filing/0001213900-26-076526.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1681682/000121390026076526/0001213900-26-076526-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1681682/000121390026076526/ea0297455-8k_endra.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-09T10:10:04.534048+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}